Reimbursement

• as reimbursement data become more complex and evolve rapidly, pharmaceutical professionals are spending more time on data collection instead on deriving insights
• visually tracking changes in paragraph texts of innovative medicines is very challenging
• sifting through years of reimbursement history feels like searching for a needle in a haystack
• reconstructing the reimbursement history for new acquisitions and their landscape requires enormous efforts
• changes are easily missed in absence of automated, systematic solutions

CTG/CRM agendas

• manually processing the bimonthly pdf files of CTG agendas is frustrating and time consuming
• the work is often duplicated over multiple business units
• the data lack structure to be easily browsed
• CTG agendas still have to be manually filtered to sort out events relevant to business units
• reconstructing CTG file tracks by manually sifting through series of unstructured pdfs is laborious
• interpretation of CTG/CRM tracks in a larger context of approval and final reimbursement events is time-consuming when data needs to be collected from multiple sources (EMA, RIZIV/INAMI, FAGG)